देश: संयुक्त राज्य
भाषा: अंग्रेज़ी
स्रोत: NLM (National Library of Medicine)
POTASSIUM ACETATE (UNII: M911911U02) (POTASSIUM CATION - UNII:295O53K152), SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698), SODIUM ACETATE (UNII: 4550K0SC9B) (ACETATE ION - UNII:569DQM74SC, SODIUM CATION - UNII:LYR4M0NH37), MAGNESIUM CHLORIDE (UNII: 02F3473H9O) (MAGNESIUM CATION - UNII:T6V3LHY838, CHLORIDE ION - UNII:Q32ZN48698), CALCIUM CHLORIDE (UNII: M4I0D6VV5M) (CALCIUM CATION - UNII:2M83C4R6ZB, CHLORIDE ION - UNII:Q32ZN48698)
B. Braun Medical Inc.
POTASSIUM ACETATE
POTASSIUM ACETATE 1.96 g in 20 mL
INTRAVENOUS
PRESCRIPTION DRUG
Hyperlyte® CR is indicated for use as a supplement to parenteral nutritional solutions containing amino acids, dextrose and/or other calorie sources delivered by central venous or peripheral infusion, to facilitate amino acid utilization and maintain electrolyte balance in adults. Hyperlyte® CR (Multi-Electrolyte Concentrate) is also indicated as a source of replacement electrolytes for the depleted adult patient during parenteral therapy. Hyperlyte® CR is contraindicated in clinical conditions where the administration of potassium, sodium, calcium, magnesium, or chloride could be clinically detrimental. Hyperlyte® CR is not intended for pediatric use.
Hyperlyte® CR (Multi-Electrolyte Concentrate) is supplied sterile and nonpyrogenic in Pharmacy Bulk Package with solid stoppers, packaged 12 per case. Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. It is recommended that the product be stored at room temperature (25°C); however, brief exposure up to 40°C does not adversely affect the product.
unapproved drug other
HYPERLYTE CR- MULTI ELECTROLYTE CONCENTRATE INJECTION, SOLUTION, CONCENTRATE B. BRAUN MEDICAL INC. _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- HYPERLYTE CR HYPERLYTE CR MULTI-ELECTROLYTE CONCENTRATE (20 ML/DOSE) PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION FOR INTRAVENOUS INFUSION ONLY. MUST BE DILUTED PRIOR TO INJECTION. CONTAINS NO PHOSPHATE. DESCRIPTION A pharmacy bulk package is a container of a sterile preparation for parenteral use that contains many single doses. The contents are intended for use in a pharmacy admixture service and are restricted to the preparation of admixtures for intravenous infusion. Hyperlyte® CR (Multi-Electrolyte Concentrate) is a sterile, nonpyrogenic, concentrated solution of intra- and extracellular electrolytes, excluding phosphate. No bacteriostatic or antimicrobial agent has been added. Each 20 mL contains: Potassium Acetate USP 1.96 g; Sodium Chloride USP 1.17 g; Sodium Acetate Trihydrate USP 0.68 g; Magnesium Chloride Hexahydrate USP 0.51 g; Calcium Chloride Dihydrate USP 0.37 g; Water for Injection USP qs pH adjusted with Glacial Acetic Acid USP as needed pH: 5.2 (5.0-5.4); Calculated Osmolarity: 5500 mOsmol/liter Concentration of Electrolytes (mEq/20 mL dose): Sodium 25; Potassium 20; Calcium 5; Magnesium 5; Chloride 30; Acetate 30 The formulas of the active ingredients are: INGREDIENTS MOLECULAR FORMULA MOLECULAR WEIGHT Potassium Acetate USP CH COOK 98.14 Sodium Chloride USP NaCl 58.44 Sodium Acetate Trihydrate USP CH COONa•3H O 136.08 Magnesium ® 3 3 2 Magnesium Chloride Hexahydrate USP MgCl •6H O 203.30 Calcium Chloride Dihydrate USP CaCl •2H O 147.02 CLINICAL PHARMACOLOGY Hyperlyte® CR provides a source of intra- and extracellular electrolytes in suitable amounts, to help maintain normal cellular metabolism during total parenteral nutrition (TPN) and other parenteral therapy in adults. Use of properly diluted पूरा दस्तावेज़ पढ़ें